Skip to main content

Day: August 5, 2020

Letter to Shareholders Regarding Rafarma Acquisition by R. & D. Biocogency Laboratories Inc.

Ljubljana, Slovenia, Aug. 05, 2020 (GLOBE NEWSWIRE) — Rafarma Pharmaceuticals, Inc. OTC:(RAFA) presents the following letter to Rafarma shareholders from CEO Vladimir Dolgolenko:To Our Shareholders:During these exciting times I wanted to reach out to our shareholders and clarify some questions I have received. As recently announced, there will be a change in control forthcoming for Rafarma. The change in control will not affect the current share structure of the company. There has been no dilution and there are no current plans for dilution or issuance of additional shares as part of this acquisition. Our acquirer, R&D Biocogency Laboratories Inc. (“Biocogency”), brings an enormous amount of potential and an already proven business model. As stated in our previous release, Biocogency’s 2019 revenues were approximately $73 million...

Continue reading

Nano Dimension’s President & CEO Invests in the Company

Reports on Company Status in a Statement to the ShareholdersBoca Raton, Florida, Aug. 05, 2020 (GLOBE NEWSWIRE) — Nano Dimension Ltd. (Nasdaq: NNDM), a leading Additively Manufactured Electronics (AME)/PE (Printed Electronics) provider, announced today that Yoav Stern, who joined the Company as President and Chief Executive Officer in January 2020, is purchasing from the Company a Series A warrant to buy up to 6,880,402 of the Company’s ADSs for an aggregate exercise price of $5,160,302. The cost of the warrant is $150,000. The warrant will vest over a period of two and a half years and will have a term of seven years. 

Continue reading

Gritstone Oncology Reports Second Quarter Financial Results and Recent Highlights

EMERYVILLE, Calif., Aug. 05, 2020 (GLOBE NEWSWIRE) — Gritstone Oncology, Inc. (Nasdaq: GRTS), a clinical-stage biotechnology company developing the next generation of cancer immunotherapies to fight multiple cancer types, today reported financial results for the second quarter ended June 30, 2020 and reviewed business highlights.“We have made important advances in our two cancer immunotherapy programs, GRANITE and SLATE, demonstrating early signals of clinical benefit together with a well-tolerated safety profile,” said Andrew Allen, M.D., Ph.D., co-founder, president and chief executive officer of Gritstone Oncology. “Building upon our data presented 6 months ago, we have shown that GRANITE, our personalized ‘N of 1’ therapy, consistently elicited large numbers of Class I HLA-presented neoantigen-specific CD8+ T cells in all patients...

Continue reading

Natural Health Trends Reports Second Quarter 2020 Financial Results

– Revenue of $16.4 million increased 10% from the first quarter of 2020– Aggressive cost cutting measures facilitated a return to profitability in the second quarter of 2020– Strong balance sheet with ample liquidity and $93.2 million in cash and cash equivalents– Declared a quarterly cash dividend of $0.20 per shareHONG KONG, Aug. 05, 2020 (GLOBE NEWSWIRE) — Natural Health Trends Corp. (NASDAQ: NHTC), a leading direct-selling and e-commerce company that markets premium quality personal care, wellness and “quality of life” products under the NHT Global brand, today announced its financial results for the second quarter ended June 30, 2020.Second Quarter 2020 Financial HighlightsRevenue of $16.4 million increased 10% compared to $14.9 million in the first quarter of 2020 and decreased 30% compared to $23.4 million in the second quarter...

Continue reading

Seanergy Maritime Holdings Corp. Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2020

Highlights of the Second Quarter of 2020:Net revenues after voyage expenses: $4.7 million in Q2 2020 compared to $8.0 million in Q2 2019Net loss: $11.3 million in Q2 2020, as compared to $6.9 million in Q2 2019EBITDA1: ($2.1) million in Q2 2020, as compared to $1.7 million in Q2 2019Highlights of First Six Months of 2020:Net revenues after voyage expenses: $12.3 million in 6M 2020 compared to $14.8 million in 6M 2019Net loss: $19.6 million in 6M 2020, as compared to $15.5 million in 6M 2019 EBITDA1: ($1.1) million in 6M 2020 as compared to $2.1 million in 6M 2019Second Quarter of 2020 and Recent Developments:Delivered one vessel to Glencore under a long-term time-charter following scrubber installationSuccessfully completed a series of equity capital markets transactionsAcquired one Capesize vessel with prompt deliveryCompleted refinancing...

Continue reading

Gold X Mining Commences Planned Engineering of Northern Access Road

Gold X signs agreement with CM Engineering of Suriname for design of Northern Access Route connecting Toroparu to tidewater at Buckhall LIDAR based engineered design expected to be completed in September 2020 Remaining US$250,000 of debt has been converted into equity at C$3.20 per share leaving Gold X debt free and 100% owner of ToroparuVANCOUVER, British Columbia, Aug. 05, 2020 (GLOBE NEWSWIRE) — Gold X Mining Corp. (TSX.V: GLDX, OTCQX: SSPXF) (“Gold X” or the “Company”) is pleased to announce commencement of engineering and design for a new road link that will replace use of the historical road route between the Toroparu Gold Project and Tidewater, decreasing both capital and operating costs of access for the project. The new road link will connect Toroparu to the Barama – Buckhall Landing Road (the “Barama Road”) which also...

Continue reading

Goodfood Completes its Previously Announced Bought Deal Public Offering of Common Shares and Announces the Exercise in Full of the Over-Allotment Option for a Total Offering of $40 Million

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES.MONTREAL, Aug. 05, 2020 (GLOBE NEWSWIRE) — Goodfood Market Corp. (“Goodfood” or the “Company”) (TSX:FOOD), a leading online grocery company in Canada, is pleased to announce that it has closed its previously announced bought deal public offering (the “Offering”), pursuant to which a syndicate of underwriters co-led by Desjardins Capital Markets and Stifel GMP (together, the “Co-Lead Underwriters”), and including National Bank Financial Inc., Scotia Capital Inc., Raymond James Ltd., RBC Dominion Securities Inc., Canaccord Genuity Corp., Eight Capital and Acumen Capital Finance Partners Limited (collectively with the Co-Lead Underwriters, the “Underwriters”) purchased an aggregate of 5,788,000 common shares of the Company (the...

Continue reading

Goodfood réalise son placement public d’actions ordinaires par voie de prise ferme annoncé précédemment et annonce l’exercice intégral de l’option de surallocation pour un placement total de 40 M$

NE PAS DISTRIBUER AUX AGENCES DE PRESSE DES ÉTATS-UNIS NI DIFFUSER AUX ÉTATS‑UNIS.MONTRÉAL, 05 août 2020 (GLOBE NEWSWIRE) — Marché Goodfood Corp. (« Goodfood » ou la « Société ») (TSX : FOOD), un chef de file canadien de l’épicerie en ligne, a le plaisir d’annoncer la clôture de son placement public par voie de prise ferme annoncé précédemment (le « placement »), aux termes duquel un syndicat de prise ferme mené conjointement par Desjardins Marché des capitaux et Stifel GMP (collectivement, les « preneurs fermes co-chefs de file »), et comprenant Financière Banque Nationale Inc., Scotia Capitaux Inc., Raymond James Ltée, RBC Dominion valeurs mobilières Inc., Corporation Canaccord Genuity, Eight Capital et Acumen Capital Finance Associés Limitée (collectivement avec les preneurs fermes co-chefs de file, les « preneurs fermes ») ont...

Continue reading

Verizon Ventures leads €4 Million Series A financing round in PICadvanced

BASKING RIDGE, N.J., Aug. 05, 2020 (GLOBE NEWSWIRE) — Verizon Ventures today announced it led a €4 million ($4.5 million) Series A financing round in PICadvanced (PICa), a developer of cost-effective optics and photonics solutions for telecom applications. Joining Verizon Ventures in the round is a 200M Co-investment Fund managed by PME Investimentos, which makes co-investments in high-growth Portuguese startups. Founded in 2014 and based in Ílhavo, Portugal, PICa has been active in the development of optoelectronic transceivers for a new telecommunications network standard called NG-PON2 (Next-Generation Passive Optical Network 2). Leveraging its expertise, the company aims to provide innovative solutions for the Passive Optical Network (PON) market. It has solved many complex problems through optics, from design and development...

Continue reading

CV Sciences, Inc. Announces Launch of Happy Lane™ CBD Product Line

SAN DIEGO, Aug. 05, 2020 (GLOBE NEWSWIRE) — CV Sciences, Inc. (OTCQB:CVSI) (the “Company”, “CV Sciences”, “our”, “us” or “we”), a preeminent leader in hemp derived cannabidiol (CBD) products, today announced the launch of its new Happy Lane™ CBD product line.Happy Lane™ non-GMO, hemp derived CBD products are manufactured with 0.00% THC (“THC-free”) and formulated using CV Sciences’ rigorous standards for quality, verified by a third party laboratory for purity, strength and composition.Leveraging the success of the Company’s top selling PlusCBD™ product line, CV Sciences plans to make Happy Lane™ broadly available to U.S. consumers through new distribution channels, including the $650 billion convenience store channel.Happy Lane™ is now available at select natural products retailers nationwide in six product SKUs and multiple form...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.